ROSHNI PATEL: Open Payments
NPI 1184342685 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46 in 2 payments from 2 companies in 2025. Trend: 2023 $26 · 2024 $44 · 2025 $46
Food & beverage: $46
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: ENTYVIO.
Industry payments across NY — which companies pay providers there.
